Faculty profile

Evelyne Vinet

ResearcherMedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Evelyne Vinet

Researcher

Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
16 publications in the last five years, latest in 2026.
Principal investigator on 7 research grants (7 CIHR), most recently in 2022.
Supervised 1 trainee who won CIHR awards, most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,037

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Pregnancy Systemic Lupus Erythematosus Antiphospholipid Antibodies Ankylosing Spondylitis Chronic Inflammatory Diseases Inflammatory Bowel Diseases Rheumatoid Arthritis Rotavirus Vaccine

Latest papers

ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).
The Lancet. Rheumatology · 2026
Serum perfluorooctane sulfonate and perfluorooctanoic acid concentrations and longitudinal systemic lupus outcomes.
Journal of autoimmunity · 2026
The lupus damage index revision program: Results from the item generation and reduction phases.
Lupus science & medicine · 2026

All 49 publications

Latest funding

Mental Health in Individuals with Autoimmune Rheumatic Diseases During the Transition to Parenthood: A Mixed Methods Study to Identify Associated Factors and Support Needs
CIHR · 2022 · Co-investigator
$198,900
Risk stratification and personalized therapy in lupus pregnancies
CIHR · 2022 · Nominated PI
$757,350
The "Atrial FIBrillation in Pregnancy: assessing seveRe matErnal morbidity and anticoagulation strateGies" (AFIB-PREG) Study
CIHR · 2021 · Co-investigator
$275,400

All 16 grants and awards

49 publications.

ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).

Arnaud L, Monticielo OA, Piga M, Costedoat-Chalumeau N, Touma Z, Ruiz-Irastorza G, Bae SC, Bernatsky S, Bonfa E, Bottazzi F, Cervera R, Chehab G, Clarke AE, Dall'era M, Duarte-Garcia A, Espinosa G, Fortin PR, Fredi M, Gómez-Puerta JA, Izuka S, Jönsen A, Khmelinskii N, Legge A, Meisalu S, Moroni L, Orsolini G, Padjen I, Petri M, Pons-Estel G, Ramirez GA, Ramsey-Goldman R, Sciascia S, Tincani A, Triggiani M, Ugarte-Gil MF, Vinet E, Vital EM, Mosca M, Tani C, ERN ReCONNET–SLICC–SLEuro rare SLE taskforce member panel

The Lancet. Rheumatology2026

DOI: 10.1016/s2665-9913(26)00141-4 PMID: 42648304

Serum perfluorooctane sulfonate and perfluorooctanoic acid concentrations and longitudinal systemic lupus outcomes.

Zhao N, Rochepeau A, Sauvé S, Mendel A, Vinet E, Verner MA, Rauch J, Pineau CA, Lukasa L, Grenier LP, Kalache F, Bernatsky S

Journal of autoimmunity2026

DOI: 10.1016/j.jaut.2026.103636 PMID: 42753309

The lupus damage index revision program: Results from the item generation and reduction phases.

Kundakci B, Barber MRW, Clarke AE, Johnson SR, Mak A, Brunner HI, Inanc M, Ramsey-Goldman R, Ruiz-Irastorza G, Ginzler EM, Hanly JG, Legge A, Aranow C, Arnaud L, Costedoat-Chalumeau N, Gladman DD, Jacobsen S, Petri MA, Silva CA, Vinet E, Voskuyl AE, SDI Revision Leadership Team, SDI Revision Literature Review Groups, SDI Revision Delphi Panel, SDI Revision Item Reduction Committee, SDI Revision Clinical Domain Groups, Bruce IN

Lupus science & medicine2026

DOI: 10.1136/lupus-2026-002282 PMID: 42586611

Artificial Intelligence-Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives.

Stein OA, Lee JLF, Vinet E, Mendel A, Pineau CA, Kalache F, Grenier LP, Bernatsky S

Arthritis care & research2026

DOI: 10.1002/acr.80087 PMID: 42138311

Forgotten costs of systemic lupus erythematosus: estimating indirect healthcare costs in a national prospective observational Canadian lupus cohort.

Barber MRW, St Pierre Y, Peschken CA, Legge A, Hanly JG, Vinet E, Pineau CA, Bernatsky S, Touma Z, Urowitz MB, Gladman DD, Fortin PR, Clarke AE

Lupus science & medicine2026

DOI: 10.1136/lupus-2025-001851 PMID: 42044933

Patient perspectives on clinical trial participation for novel advanced therapies: a focus group study in systemic lupus erythematosus.

Stein OA, Lee JLF, Vinet E, Mendel A, Pineau CA, Kalache F, Grenier LP, Mielczarek L, Bernatsky S

Rheumatology international2026

DOI: 10.1007/s00296-026-06071-x PMID: 41571944

Anti-myxovirus resistance protein 1: a novel biomarker for autoimmune myositis and interstitial lung disease in systemic lupus erythematosus.

Krustev E, Fritzler MJ, Bernatsky S, St Pierre Y, Sciore PJ, Vinet E, Pineau CA, Mendel A, Kalache F, Grenier LP, Cotton T, Niaki OZ, Choi MY

Annals of the rheumatic diseases2025

DOI: 10.1016/j.ard.2025.01.031 PMID: 39948002

Trends in medications for autoimmune disorders during pregnancy and factors for their discontinuation: a population-based study.

Mainbourg S, Sheehy O, Gorgui J, Vinet E, Bérard A

BMC pregnancy and childbirth2024

DOI: 10.1186/s12884-024-06932-y PMID: 39563243

N-terminal pro-brain natriuretic peptide is a biomarker for cardiovascular damage in systemic lupus erythematous: a cross-sectional study.

Sacre K, Vinet E, Pineau CA, Mendel A, Kalache F, Grenier LP, Huynh T, Bernatsky S

Rheumatology (Oxford, England)2024

DOI: 10.1093/rheumatology/kead522 PMID: 37802912

Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases.

Schreiber K, Giles I, Costedoat-Chalumeau N, Nelson-Piercy C, Dolhain RJ, Mosca M, Förger F, Fischer-Betz R, Molto A, Tincani A, Pasquier E, Marin B, Elefant E, Salmon J, Bermas BL, Sammaritano L, Clowse MEB, Chambers C, Buyon J, Inoue SA, Agmon-Levin N, Aguilera S, Emadi SA, Andersen J, Andrade D, Antovic A, Arnaud L, Christiansen AA, Avcin T, Badreh-Wirström S, Bertsias G, Bini I, Bobirca A, Branch W, Brucato A, Bultink I, Capela S, Cecchi I, Cervera R, Chighizola C, Cobilinschi C, Cuadrado MJ, Dey D, Etomi O, Espinosa G, Flint J, Fonseca JE, Fritsch-Stork R, Gerosa M, Glintborg B, Skorpen CG, Goulden B, Graversgaard C, Gunnarsson I, Gupta L, Hetland M, Hodson K, Hunt BJ, Isenberg D, Jacobsen S, Khamashta M, Levy R, Linde L, Lykke J, Meissner Y, Moore L, Morand E, Navarra S, Opris-Belinski D, Østensen M, Ozawa H, Perez-Garcia LF, Petri M, Pons-Estel GJ, Radin M, Raio L, Rottenstreich A, Ruiz-Irastorza G, Tunjić SR, Rygg M, Sciascia S, Strangfeld A, Svenungsson E, Tektonidou M, Troldborg A, Vinet E, Vojinovic J, Voss A, Wallenius M, Andreoli L

The Lancet. Rheumatology2023

DOI: 10.1016/s2665-9913(23)00215-1 PMID: 38251494

Mental Health in Individuals with Autoimmune Rheumatic Diseases During the Transition to Parenthood: A Mixed Methods Study to Identify Associated Factors and Support Needs

Co-investigatorCIHR2022Project Grant

Principal investigators: Da Costa, Deborah M

Keywords: Autoimmune Rheumatic Diseases; Gender Roles; Mental Health; Mixed-Methods; Parenthood; Support Preferences

$198,900

Risk stratification and personalized therapy in lupus pregnancies

Nominated PICIHR2022Project Grant

Principal investigators: Vinet, Evelyne

Keywords: Adverse Pregnancy Outcomes; Antiphosphatidylserine/Prothrombin Antibodies (Aps/Pt); Antiphospholipid Antibodies; Disease Flare; Lupus Low Disease Activity State (Lldas); Placenta-Mediated Complications; Pregnancy; Risk Factors; Systemic Lupus Erythematosus; Therapeutic Drug Monitoring

$757,350

The "Atrial FIBrillation in Pregnancy: assessing seveRe matErnal morbidity and anticoagulation strateGies" (AFIB-PREG) Study

Co-investigatorCIHR2021Project Grant

Principal investigators: Malhamé, Isabelle; Bérard, Anick; Bernatsky, Sasha R; Pilote, Louise

Keywords: Atrial Fibrillation; Cardiovascular Health; Maternal Mortality; Pregnancy; Pregnancy-Related Mortality; Severe Maternal Morbidity

$275,400

Tumour necrosis factor inhibitors as a risk factor for serious infections in pregnant women with chronic inflammatory diseases and their offspring: a population-based cohort study

SupervisorCIHR2021Doctoral Research Award: Canada Graduate Scholarships

Principal investigators: Flatman, Leah K

Keywords: Administrative Database; Chronic Inflammatory Diseases; Clinical Epidemiology; Epidemiology; Female Reproductive Health; Pharmacoepidemiology; Pregnancy; Rotavirus Vaccine; Serious Infections; Tumour Necrosis Factor Inhibitors

$105,000

Risk of infections with tumour necrosis factor inhibitors (TNFi) in pregnant women and their offspring

Nominated PICIHR2019Operating Grant: ECI grants in Maternal, Reproductive, Child & Youth Health

Principal investigators: Vinet, Evelyne

Keywords: Ankylosing Spondylitis; Chronic Inflammatory Diseases; Inflammatory Bowel Diseases; Pregnancy; Psoriasis; Psoriatic Arthritis; Rheumatoid Arthritis; Rotavirus Vaccine; Serious Infections; Tumour Necrosis Factor Inhibitors

$105,000

Risk of infections with tumour necrosis factor inhibitors (TNFi) in pregnant women and their offspring

Nominated PICIHR2019Project Grant

Principal investigators: Vinet, Evelyne

Keywords: Administrative Database; Ankylosing Spondylitis; Chronic Inflammatory Diseases; Inflammatory Bowel Diseases; Pregnancy; Psoriasis And Psoriatic Arthritis; Rheumatoid Arthritis; Rotavirus Vaccine; Serious Infections; Tumour Necrosis Factor Inhibitors (Tnfi)

$382,500

Enhancing CAN-AIM capacity to respond to drug safety and effectiveness queries

Co-investigatorCIHR2019DSEN team grants: MAGIC and CAN-AIM

Principal investigators: Bernatsky, Sasha R; Abrahamowicz, Michal M; Afif, Waqqas; Awadalla, Philip; Bérard, Anick; Buckeridge, David L; Hazlewood, Glen S; Hohl, Corinne M; Kowalec, Kaarina A; Moride, Yola; Moura, Cristiano S; Pilote, Louise; Tremlett, Helen L

Keywords: Comparative Effectiveness And Safety; Confounding Bias; Exposure Measurement Errors; Pharmacoepidemiology; Prospective Studies; Statistical Modelling

$2,550,000

The Lupus prEGnAnCY (LEGACY) Cohort

Nominated PICIHR2017Catalyst Grant: Musculoskeletal Health and Arthritis

Principal investigators: Vinet, Evelyne; Buyon, Jill P; Clowse, Megan E; Laskin, Carl A; Salmon, Jane

Keywords: Antiphospholipid Antibodies; Pregnancy; Prospective Cohort; Systemic Lupus Erythematosus

$100,000

Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs

Co-investigatorCIHR2017Rapid Funding for DSEN Targeted Research

Principal investigators: Bernatsky, Sasha R; Boire, Gilles; Bykerk, Vivian P; Lakatos, Peter; Maksymowych, Walter P; Moura, Cristiano S; Targownik, Laura E

Keywords: Des

$1,769,650

Hydroxychloroquine in systemic lupus

Co-investigatorCIHR2017Project Grant

Principal investigators: Bernatsky, Sasha R; Hazlewood, Glen S

Keywords: Drug Effectiveness; Drug Safety; Epidemiology; Rheumatic Diseases; Systemic Lupus Erythematosis

$342,340

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Evelyne Vinet

Research

Latest papers

Latest funding

ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).

Serum perfluorooctane sulfonate and perfluorooctanoic acid concentrations and longitudinal systemic lupus outcomes.

The lupus damage index revision program: Results from the item generation and reduction phases.

Artificial Intelligence-Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives.

Forgotten costs of systemic lupus erythematosus: estimating indirect healthcare costs in a national prospective observational Canadian lupus cohort.

Patient perspectives on clinical trial participation for novel advanced therapies: a focus group study in systemic lupus erythematosus.

Anti-myxovirus resistance protein 1: a novel biomarker for autoimmune myositis and interstitial lung disease in systemic lupus erythematosus.

Trends in medications for autoimmune disorders during pregnancy and factors for their discontinuation: a population-based study.

N-terminal pro-brain natriuretic peptide is a biomarker for cardiovascular damage in systemic lupus erythematous: a cross-sectional study.

Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases.

Frequent collaborators

Evelyne Vinet

Sasha Bernatsky

Sasha Bernatsky

Arielle Mendel

Arielle Mendel

Marie Hudson

Zahi Touma

Stephanie Keeling

Caroline Quach

Vinita Haroun

Murray Urowitz

Natalie Dayan

Sasha Bernatsky

Mark Matsos

Elham Rahme

Gordon Guyatt

Deborah Da Costa

Murray Baron

Joyce Rauch

Moshe Ben-Shoshan

Christine Peschken

Jessica Widdifield

Louise Pilote

Ronald van Vollenhoven

Thao Huynh

Jason Karamchandani

Jason Karamchandani

Robert Platt

Louise Pilote

Nader Khalidi

John Hanly

Michal Abrahamowicz

Paul Fortin